|
| 注射用血栓通（冻干）上市后医院临床应用与不良反应集中监测 |
| Centralized Monitoring of Clinical Use and Adverse Reaction of Xueshuantong Injection (Freeze dried) Post marketing in the Hospital |
| |
| DOI： |
| 中文关键词: 注射用血栓通（冻干） 医院集中监测 上市后再评价 药品不良反应 合理用药 |
| 英文关键词:Xueshuantong injection (freeze dried) Hospital centralized monitoring Post marketing reassessment Adverse drug reation Rational drug use |
| 基金项目: |
|
| 摘要点击次数: 1258 |
| 全文下载次数: 1169 |
| 中文摘要: |
| 摘 要 目的：对注射用血栓通（冻干）上市后临床应用情况进行研究评价，为规范和指导临床合理用药提供依据。方法：采用医院集中监测的方法，以本院2015年8月～2016年4月入院并使用注射用血栓通（冻干）的住院患者为研究对象，记录患者基本情况、用药情况和不良反应发生情况，并进行数据统计和分析。结果：共观察病例1 830例，其中18.42%患者无用药指征；6.45%患者用药时间过长；有16例发生不良反应，发生率为0.87%，属于偶见。结论：我院注射用血栓通（冻干）临床应用欠规范，提示临床用药应严格按照说明书适应证及疗程，并密切监测患者有无不良反应发生，以确保临床用药安全、有效。 |
| 英文摘要: |
| ABSTRACT Objective:To assess the clinical use of Xueshuantong injection (freeze dried), and to provide reference for rational drug use. Methods:Based on hospital centralized monitoring method, the clinical data of Xueshuantong injection (freeze dried) in our hospital from August 2015 to April 2016 was tracked and analyzed. Results:A total of 1 830 inpatients were enrolled in this study. Among them, 18.42% were not in accordance with the medication purpose, and 6.45% were received a over long course of treatment. And 16 cases of adverse drug reaction (ADR) were monitored, with the ADR incidence rate of 0.87%, which showed good safety. Conclusion:The clinical use of Xueshuantong injection (freeze dried) in our hospital was partly irrational. In order to ensure the safe, effective and economical use, the drug should be strictly used according to the instructions. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
